Premature Birth clinical trials at UCLA
3 in progress, 2 open to eligible people
Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants
open to all eligible people
A comprehensive analysis of the impact of exogenous enteral DHA and ARA supplementation on lipid metabolism including the production of downstream derived mediators and how this impacts important biological pathways such as metabolism, inflammation, and organogenic factors.
Los Angeles 5368361, California 5332921 and other locations
Follow-up Visit of High Risk Infants
open to eligible people ages 18 months to 26 months
The NICHD Neonatal Research Network's Follow-Up study is a multi-center cohort in which surviving extremely low birth-weight infants born in participating network centers receive neurodevelopmental, neurosensory and functional assessments at 22-26 months corrected age (Infants born prior to July 1, 2012 were seen at 18-22 months corrected age). Data regarding pregnancy and neonatal outcome are collected prospectively. The goal is to identify potential maternal and neonatal risk factors that may affect infant neurodevelopment.
Los Angeles 5368361, California 5332921 and other locations
IBP-9414 for the Prevention of Necrotizing Enterocolitis - The Connection Study
Sorry, in progress, not accepting new patients
IBP-9414 will be evaluated in preterm infants with a birth weight of 500-1500g, compared to placebo with regards to efficacy and safety in the prevention of necrotizing enterocolitis.
Los Angeles 5368361, California 5332921 and other locations
Our lead scientists for Premature Birth research studies include Kara L. Calkins, MD.
Last updated: